Candel Therapeutics Income Statement (2020-2023) | CADL

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Revenue & cost
Revenue 0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.61M-0.64M-0.67M4.52M
Operating items
Research & Development 1.62M1.81M3.53M2.75M3.29M5.26M3.85M5.42M5.02M5.38M4.97M5.47M5.93M5.84M7.26M
Selling, General & Administrative 0.73M0.97M2.62M1.94M2.04M2.79M3.92M3.60M3.76M3.54M3.16M4.16M3.65M3.02M3.06M
Operating Expenses 2.35M2.78M6.16M4.69M5.33M8.06M7.77M9.02M8.78M8.91M8.13M9.63M9.58M8.86M10.32M
Operating Income -2.32M-2.75M-6.12M-4.66M-5.30M-8.03M-7.74M-8.99M-8.75M-8.88M-8.10M-9.63M-9.58M-8.86M-10.32M
EBIT -2.32M-2.75M-6.12M-4.66M-5.30M-8.03M-7.74M-8.99M-8.75M-8.88M-8.10M-9.63M-9.58M-8.86M-10.32M
Non-operating items
Interest & Investment Income -0.07M0.04M0.05M-0.01M-0.01M-0.01M-0.01M-0.17M0.07M0.34M0.80M0.71M0.45M0.50M0.41M
Non Operating Income 0.58M0.20M-4.35M0.19M-11.78M-8.13M9.34M8.11M4.60M0.19M3.02M0.84M-0.04M0.43M-0.78M
Net income details
EBT -2.39M-2.71M-6.08M-4.67M-5.32M-8.04M-7.75M-9.16M-8.86M-9.06M-7.88M-9.53M-9.77M-9.03M-5.39M
Profit After Tax -1.77M-2.55M-10.48M-4.48M-17.08M-16.16M1.60M-0.90M-4.15M-8.69M-5.09M-8.80M-9.61M-8.44M-11.10M
Income from Continuing Operations -2.39M-2.71M-6.08M-4.67M-5.32M-8.04M-7.75M-9.16M-8.86M-9.06M-7.88M-9.53M-9.77M-9.03M-5.39M
Consolidated Net Income -2.39M-2.71M-6.08M-4.67M-5.32M-8.04M-7.75M-9.16M-8.86M-9.06M-7.88M-9.53M-9.77M-9.03M-5.39M
Income towards Parent Company -2.39M-2.71M-6.08M-4.67M-5.32M-8.04M-7.75M-9.16M-8.86M-9.06M-7.88M-9.53M-9.77M-9.03M-5.39M
Net Income towards Common Stockholders -2.39M-2.71M-6.08M-4.67M-5.32M-8.04M-7.75M-9.16M-8.86M-9.06M-7.88M-9.53M-9.77M-9.03M-5.39M
Additional items
EPS (Basic) -0.15-0.22-0.90-0.38-1.46-0.690.51-0.03-0.14-0.30-0.17-0.30-0.33-0.29-0.38
EPS (Weighted Average and Diluted) -0.39-0.690.51-0.03-0.14-0.30-0.17-0.30-0.33-0.29-0.38
Shares Outstanding (Weighted Average) 24.80M24.80M24.80M28.69M28.69M28.69M28.69M28.89M28.89M28.92M28.92M28.92M28.92M
Shares Outstanding (Diluted Average) 11.72M23.33M18.87M28.69M28.81M28.89M28.82M28.92M28.92M28.92M
EBITDA -2.01M-2.56M-10.53M-4.66M-4.48M-16.16M1.60M-8.99M-8.75M-8.88M-8.10M-9.63M-9.58M-8.86M-10.32M
Interest Expenses 0.18M0.52M0.58M0.61M0.64M0.67M-4.52M